These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 8793383)
1. Characterization of a peptide antibody against a C-terminal part of human and mouse cytosolic thymidine kinase, which is a marker for cell proliferation. He Q; Skog S; Wang N; Eriksson S; Tribukait B Eur J Cell Biol; 1996 Jun; 70(2):117-24. PubMed ID: 8793383 [TBL] [Abstract][Full Text] [Related]
2. Cytosolic thymidine kinase is a specific histopathologic tumour marker for breast carcinomas. He Q; Mao Y; Wu J; Decker C; Merza M; Wang N; Eriksson S; Castro J; Skog S Int J Oncol; 2004 Oct; 25(4):945-53. PubMed ID: 15375544 [TBL] [Abstract][Full Text] [Related]
3. Effect of C-terminal of human cytosolic thymidine kinase (TK1) on in vitro stability and enzymatic properties. Zhu C; Harlow LS; Berenstein D; Munch-Petersen S; Munch-Petersen B Nucleosides Nucleotides Nucleic Acids; 2006; 25(9-11):1185-8. PubMed ID: 17065087 [TBL] [Abstract][Full Text] [Related]
4. Investigation on cell proliferation with a new antibody against thymidine kinase 1. Wang N; He Q; Skog S; Eriksson S; Tribukait B Anal Cell Pathol; 2001; 23(1):11-9. PubMed ID: 11790855 [TBL] [Abstract][Full Text] [Related]
5. Expression of cell proliferating genes in patients with non-small cell lung cancer by immunohistochemistry and cDNA profiling. Mao Y; Wu J; Skog S; Eriksson S; Zhao Y; Zhou J; He Q Oncol Rep; 2005 May; 13(5):837-46. PubMed ID: 15809747 [TBL] [Abstract][Full Text] [Related]
6. Continuous increase in phosphorylation of cytosolic thymidine kinase during proliferation of rat hepatoma JB1 cells. Lin L; Kuroiwa N; Moriyama Y; Fujimura S Oncol Rep; 2003; 10(3):665-9. PubMed ID: 12684641 [TBL] [Abstract][Full Text] [Related]
7. Localization and characterization of the 86- and 84-kDa heat shock proteins in Hepa 1c1c7 cells. Perdew GH; Hord N; Hollenback CE; Welsh MJ Exp Cell Res; 1993 Dec; 209(2):350-6. PubMed ID: 8262153 [TBL] [Abstract][Full Text] [Related]
8. Production and characterisation of a novel chicken IgY antibody raised against C-terminal peptide from human thymidine kinase 1. Wu C; Yang R; Zhou J; Bao S; Zou L; Zhang P; Mao Y; Wu J; He Q J Immunol Methods; 2003 Jun; 277(1-2):157-69. PubMed ID: 12799048 [TBL] [Abstract][Full Text] [Related]
9. Analysis of epitope structure of PSP94 (prostate secretory protein of 94 amino acids): (I). Immuno-dominant and immuno-recessive area. Xuan JW; Wu D; Guo Y; Garde S; Baijal-Gupta M; Chin JL J Cell Biochem; 1997 May; 65(2):172-85. PubMed ID: 9136076 [TBL] [Abstract][Full Text] [Related]
10. New monoclonal antibodies against the putative immunosuppressive site of retroviral p15E. Lang MS; Oostendorp RA; Simons PJ; Boersma W; Knegt P; van Ewijk W Cancer Res; 1994 Apr; 54(7):1831-6. PubMed ID: 7511054 [TBL] [Abstract][Full Text] [Related]
11. Applicability of three anti-PrP peptide sera including staining of tonsils and brainstem of sheep with scrapie. Garssen GJ; Van Keulen LJ; Farquhar CF; Smits MA; Jacobs JG; Bossers A; Meloen RH; Langeveld JP Microsc Res Tech; 2000 Jul; 50(1):32-9. PubMed ID: 10871546 [TBL] [Abstract][Full Text] [Related]
12. Development of HIV/AIDS vaccine using chimeric gag-env virus-like particles. Kang CY; Luo L; Wainberg MA; Li Y Biol Chem; 1999 Mar; 380(3):353-64. PubMed ID: 10223338 [TBL] [Abstract][Full Text] [Related]
13. Prevention of mammary tumors with a chimeric HER-2 B-cell epitope peptide vaccine. Dakappagari NK; Douglas DB; Triozzi PL; Stevens VC; Kaumaya PT Cancer Res; 2000 Jul; 60(14):3782-9. PubMed ID: 10919651 [TBL] [Abstract][Full Text] [Related]
14. Comparative aspects of the proliferation marker thymidine kinase 1 in human and canine tumour diseases. von Euler H; Eriksson S Vet Comp Oncol; 2011 Mar; 9(1):1-15. PubMed ID: 21303450 [TBL] [Abstract][Full Text] [Related]
15. Myotonic dystrophy protein kinase monoclonal antibody generation from a coiled-coil template. Helmke SM; Lu SM; Harmon M; Glasford JW; Larsen TD; Kwok SC; Hodges RS; Perryman MB J Mol Recognit; 2006; 19(3):215-26. PubMed ID: 16680721 [TBL] [Abstract][Full Text] [Related]
16. A new cell proliferating marker: cytosolic thymidine kinase as compared to proliferating cell nuclear antigen in patients with colorectal carcinoma. Wu J; Mao Y; He L; Wang N; Wu C; He Q; Skog S Anticancer Res; 2000; 20(6C):4815-20. PubMed ID: 11205225 [TBL] [Abstract][Full Text] [Related]
17. Establishment and characterization of monoclonal and polyclonal antibodies against human intestinal fatty acid-binding protein (I-FABP) using synthetic regional peptides and recombinant I-FABP. Kajiura S; Yashiki T; Funaoka H; Ohkaru Y; Nishikura K; Kanda T; Ajioka Y; Igarashi M; Hatakeyama K; Fujii H J Immunoassay Immunochem; 2008; 29(1):19-41. PubMed ID: 18080878 [TBL] [Abstract][Full Text] [Related]
18. Substrate binding is a prerequisite for stabilisation of mouse thymidine kinase in proliferating fibroblasts. Posch M; Hauser C; Seiser C J Mol Biol; 2000 Jul; 300(3):493-502. PubMed ID: 10884346 [TBL] [Abstract][Full Text] [Related]
19. Affinity and potency of proinhibitory antipeptide antibodies against CYP2D6 is enhanced using cyclic peptides as immunogens. Schulz-Utermoehl T; Edwards RJ; Boobis AR Drug Metab Dispos; 2000 May; 28(5):544-51. PubMed ID: 10772633 [TBL] [Abstract][Full Text] [Related]
20. The titanium binding protein of Rhodococcus ruber GIN1 (NCIMB 40340) is a cell-surface homolog of the cytosolic enzyme dihydrolipoamide dehydrogenase. Siegmann A; Komarska A; Betzalel Y; Brudo I; Jindou S; Mor G; Fleminger G J Mol Recognit; 2009; 22(2):138-45. PubMed ID: 18956442 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]